$LZB

Is La-Z-Boy (LZB) Undervalued On Soft Earnings And Margin Pressure?

La-Z-Boy (LZB) reported Q1 sales of $475.69M and a net loss of $2.29M, with shares down 20% over a month. The company issued softer guidance and cited margin pressure, though long-term returns remain positive. Analysts suggest LZB may be undervalued at $32.57, with a fair value estimate of $46, driven by revenue growth and margin expansion plans.

Original reporting
Published Aug 29, 2026, 12:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 29, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$LZB
Bearish
medium confidence
Mentioned
$LZB
Relevance
6/10
alphai data visualization · based on simplywall.st
Decision brief

The 30-second read

$LZBBearishMed
01

Why it matters

The earnings miss could trigger a sell‑off, but the fair‑value gap suggests a possible buying opportunity for value investors.

02

Market read

Earnings release is the primary catalyst for LZB's stock movement and may influence the broader consumer discretionary sector.

03

What to watch

Potential upside from upcoming store acquisitions and share count reduction.

Relevance 6/10Novelty 6/10Timing: post-market

Background

La‑Z‑Boy reported Q1 results with a net loss and softer guidance, prompting a valuation discussion.

Company-level read

Ticker impact

$LZBBearishMedium confidence
Context

Q1 earnings disclosed a net loss of $2.29M and softer guidance, marking the first public report of these results.

Expected impact

Potential further decline of 3‑5% in the near term.

Evidence & confidence

First earnings release with loss and cautious outlook; investors likely to reassess valuation.

Market effects

Highlights weakness in the furniture retail sector amid margin pressure.

U.S. consumer discretionary stocks may see modest downside.

Limited to U.S. market; no broader global effect.

Counterpoint

Valuation still appears attractive at current price versus fair value estimate.

Key entities

  • La‑Z‑Boy

    U.S. furniture retailer (ticker LZB).

Related articles

$LZBMed

La-Z-Boy (LZB) Q1 2027 Earnings Call Transcript

La-Z-Boy (LZB) reported Q1 2027 earnings, highlighting a 1% decline in total delivered sales, excluding Casegoods divestitures, due to wholesale and Joybird business challenges. Retail sales grew 10%, with same-store sales up 3%. The company returned $35M to shareholders and ended the quarter with $267M in cash. La-Z-Boy is expanding its retail footprint and investing in digital transformation to drive growth.

$LZBHighAI 8/10

La-Z-Boy Incorporated Q1 2027 Earnings Call Summary

La-Z-Boy reported Q1 2027 retail growth of 10% and same-store sales up 3%, driven by store expansion and in-store execution. Wholesale performance declined due to seasonal softness. Management guided Q2 sales to $500M-$520M, with margins pressured by supply chain projects and advertising spend. The company is consolidating manufacturing and distribution centers, and divested its wholesale Casegoods business.

$MRNAMed

Dow Jones Today: The Treasury Just Did Something the Bond Market Desperately Needed

The Treasury announced it would double buybacks of longer-term notes, causing 30-year Treasury yields to drop to 5.194% and the Dow Jones to close up 0.22%. Fed minutes indicated potential rate hikes if inflation persists. Moderna's stock surged 175% after successful cancer vaccine trial data. Bitcoin rose above $68,000, driven by Treasury optimism and crypto legislation interest.

$LZBMed

La-Z-Boy Crashes Most Since 2022 As Frozen Housing Market Crushes Sofa Demand

La-Z-Boy shares fell 14% after Q2 guidance missed expectations, with sales forecast at $475.7M (down 3% YoY) and adjusted operating margin between 3.9% and 4.8%. Weak housing market conditions are suppressing demand for discretionary furniture items. Analysts cite continued investment pressures and delayed consumer spending as factors. The company's Q1 adjusted earnings were 43 cents per share, below estimates.

$MRNAMed

Stocks making the biggest moves premarket: Moderna, Lowe's, Estee Lauder & more

Moderna and Merck shares surged 57% and 6% respectively after positive cancer vaccine trial results. Marvell Technology rose 11% following a $12B Google investment deal. Keysight Technologies gained 2% on better-than-expected Q3 results. Lowe's fell 2% after lowering full-year guidance. Target declined 1.5% despite revenue beats. La-Z-Boy dropped 17% on weak Q1 earnings. Mercury Systems slid 9% on lower revenue forecasts. Toll Brothers rose 1% on Q3 earnings beats. Estee Lauder gained 7% after Q